In a groundbreaking study, researchers have analyzed tumors from nearly 500 pet cats across five countries, involving experts from the Wellcome Sanger Institute, the Ontario Veterinary College in Canada, and the University of Bern. This comprehensive research has unveiled significant genetic alterations in feline cancers that closely resemble those found in human cancers.
Environmental and Genetic Connections
Given that cats often inhabit the same environments as their owners, they are exposed to similar cancer risk factors. Utilizing DNA sequencing on tissue samples initially collected for veterinary diagnostics, the findings, published in Science, revealed that various genetic patterns in feline cancers mirror those in humans. A notable instance is the resemblance between feline mammary cancer and human breast cancer.
The implications of these findings suggest that exploring the genetic pathways involved in cancer could lead to innovative treatments targeting mutations in both species.
A Pioneering Resource for Cat Cancer Genomics
With over 10 million cats in the UK alone, cancer stands as a leading cause of illness and mortality in these pets. However, understanding the genetic basis of feline cancer has been limited until now. This study is the first of its kind to analyze cat tumors on such a large scale, creating an invaluable resource for advancing feline cancer genomics.
The research team examined around 1,000 genes associated with human cancer, comparing tumor and healthy tissue samples across 13 different types of feline cancer. The results indicated that the genetic drivers of cancer in cats often matched those found in humans.
Identifying Key Cancer Genes in Cats
Among the cancers studied, mammary carcinoma provided the clearest insights. Researchers identified seven driver genes linked to tumor development, with FBXW7 being the most prevalent, altered in over 50% of the tumors. In humans, mutations in FBXW7 are associated with worse outcomes in breast cancer, reflecting a similar trend in felines.
Additionally, the study found that certain chemotherapy drugs were more effective on tumor samples with FBXW7 mutations, suggesting a potential treatment avenue for both feline and human breast cancer.
Another crucial gene, PIK3CA, was identified in 47% of feline mammary tumors, echoing findings in human breast cancer that are already targeted with specific drugs.
Exploring Shared Mutations Across Cancer Types
The study also uncovered shared mutations in tumors affecting various systems, including blood, bone, and skin. These genetic similarities present opportunities for cross-species cancer research and the development of therapies that could benefit both cats and humans.
The 'One Medicine' approach has emerged from this research, advocating for collaboration between human and veterinary medicine. Discoveries in one field could inform the other, enhancing treatment strategies for both.
Researchers Emphasize Cross-Species Benefits
Bailey Francis from the Wellcome Sanger Institute noted that comparing cancer genomics across species can deepen our understanding of cancer causes. Professor Geoffrey Wood from the Ontario Veterinary College emphasized the importance of understanding how shared environments influence cancer risk in both cats and humans.
This pioneering research marks a significant advancement in feline oncology, opening the door to precision medicine for cats, and potentially benefiting human cancer treatments as well.
